TP53 and cancer: A considerable proportion of Dr-retrieved gene/human-gene sets (53%, 73%, and 15,7% for p53, p53 and cancer, doxorubicin condition queries, respectively) was reported to be under- or over-expressed according to different experimental conditions suggesting their possible role as putative p53-controlled genes.